BCAT1 and leukemia: In hematologic malignancies, Branched-chain Amino Acid Transaminase 1 inhibitors have been found to effectively inhibit the proliferation of Enhancer Of Zeste Homolog 2-deficient leukemia-initiating cells (EZH2-deficient leukemia-initiating cells), both in vitro and in vivo.